Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer.
Journal
Molecular cancer therapeutics
ISSN: 1538-8514
Titre abrégé: Mol Cancer Ther
Pays: United States
ID NLM: 101132535
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
12
11
2020
revised:
06
10
2021
accepted:
12
11
2021
pubmed:
25
11
2021
medline:
8
3
2022
entrez:
24
11
2021
Statut:
ppublish
Résumé
Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targetable biomarkers. TNBC is known to be most aggressive and when metastatic is often drug-resistant and uncurable. Biomarkers predicting response to therapy improve treatment decisions and allow personalized approaches for patients with TNBC. This study explores sulfated glycosaminoglycan (sGAG) levels as a predictor of TNBC response to platinum therapy. sGAG levels were quantified in three distinct TNBC tumor models, including cell line-derived, patient-derived xenograft (PDX) tumors, and isogenic models deficient in sGAG biosynthesis. The
Identifiants
pubmed: 34815360
pii: 1535-7163.MCT-20-0969
doi: 10.1158/1535-7163.MCT-20-0969
pmc: PMC8828673
mid: NIHMS1759599
doi:
Substances chimiques
Glycosaminoglycans
0
A73025
268AW7000T
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
271-281Subventions
Organisme : NCI NIH HHS
ID : U24 CA232979
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA060553
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA160688
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016059
Pays : United States
Commentaires et corrections
Type : CommentOn
Informations de copyright
©2021 American Association for Cancer Research.
Références
Histochem Cell Biol. 2016 Oct;146(4):431-44
pubmed: 27294358
Chem Sci. 2017 Jan 1;8(1):241-252
pubmed: 28451171
Nat Med. 2018 May;24(5):628-637
pubmed: 29713086
BMC Cancer. 2019 Nov 8;19(1):1065
pubmed: 31703646
Clin Exp Metastasis. 2019 Jun;36(3):257-269
pubmed: 31069566
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Chem Soc Rev. 2015 Dec 21;44(24):8773-85
pubmed: 25951946
N Engl J Med. 2021 Apr 22;384(16):1529-1541
pubmed: 33882206
Clin Cancer Res. 2017 Aug 15;23(16):4938-4944
pubmed: 28428193
Int J Oncol. 2011 Dec;39(6):1421-8
pubmed: 21850370
J Thorac Oncol. 2018 Jun;13(6):779-791
pubmed: 29526824
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
OMICS. 2012 Mar;16(3):79-89
pubmed: 22401653
Cancer Chemother Pharmacol. 2004 Feb;53(2):95-101
pubmed: 14605864
Ann Oncol. 2018 Dec 1;29(12):2341-2347
pubmed: 30335131
J Clin Med. 2019 Sep 30;8(10):
pubmed: 31574977
J Surg Res. 2017 Nov;219:310-318
pubmed: 29078898
Breast Cancer Res Treat. 2018 Jul;170(2):221-234
pubmed: 29532339
Int J Oncol. 2007 Dec;31(6):1415-23
pubmed: 17982668
Expert Opin Pharmacother. 2020 Apr;21(6):687-699
pubmed: 32052646
Curr Protoc Mouse Biol. 2013 Mar 01;3(1):21-9
pubmed: 26069021
Glycobiology. 2018 May 1;28(5):295-305
pubmed: 29315387
Nat Med. 2015 Nov;21(11):1318-25
pubmed: 26479923
Am J Cancer Res. 2020 Mar 01;10(3):897-907
pubmed: 32266098
J Clin Oncol. 2015 Jan 1;33(1):13-21
pubmed: 25092775
ESMO Open. 2018 May 3;3(Suppl 1):e000357
pubmed: 29765774
PLoS One. 2016 Sep 23;11(9):e0163521
pubmed: 27662655
Cancer Cell. 2015 Oct 12;28(4):500-514
pubmed: 26461094
Mod Pathol. 2017 Mar;30(3):340-349
pubmed: 27834350
Sci Rep. 2020 Jan 30;10(1):1493
pubmed: 32001757
Dalton Trans. 2015 Feb 28;44(8):3563-72
pubmed: 25524170
J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96
pubmed: 19930975
Surgery. 2020 Mar;167(3):628-630
pubmed: 31623855
J Biol Chem. 2001 Jun 22;276(25):22191-9
pubmed: 11303029
Breast Cancer Res. 2019 Mar 6;21(1):36
pubmed: 30841919
Mol Pharm. 2012 Jun 4;9(6):1795-802
pubmed: 22494465
Biosci Rep. 2018 Aug 31;38(4):
pubmed: 30054430
Inorg Chem. 2019 Jun 3;58(11):7146-7155
pubmed: 30632736
JAMA. 2019 Jan 22;321(3):288-300
pubmed: 30667505
Cancer Res. 2006 Sep 15;66(18):9308-15
pubmed: 16982776
J Control Release. 2012 Apr 30;159(2):181-8
pubmed: 22285548
J Biol Chem. 2002 Dec 13;277(50):48076-86
pubmed: 12226099
J Natl Compr Canc Netw. 2020 Mar;18(3):288-296
pubmed: 32135512
ESMO Open. 2019 May 13;4(Suppl 2):e000504
pubmed: 31231572
N Engl J Med. 2017 Jun 1;376(22):2147-2159
pubmed: 28564564
N Engl J Med. 2020 Feb 27;382(9):810-821
pubmed: 32101663
FEBS J. 2012 Apr;279(7):1177-97
pubmed: 22333131
Recent Results Cancer Res. 1985;97:77-86
pubmed: 2986247
Nat Rev Cancer. 2005 Jul;5(7):526-42
pubmed: 16069816
Mod Pathol. 2006 Oct;19(10):1344-50
pubmed: 16862076